Abiomed, Inc.
Abiomed, Inc. (ABMD) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
abmd · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Devices · 5 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Abiomed, Inc.You ABMD | $17.2B | N/A | — | — |
 NIOX Group Plc CSSPF | $274M | 40.40x | +18.3% | $0.02 |
 Drägerwerk AG & Co. KGaA DGWPF | $1.4B | 8.23x | -75.9% | $7.44 |
 Drägerwerk AG & Co. KGaA DWRKF | $1.8B | N/A | — | — |
 EKF Diagnostics Holdings plc EKDHF | $168M | 53.81x | +57.6% | $0.00 |
 Heart Tronics, Inc. HRTT | $0M | N/A | — | -$1251.61 |
Industry Average 3 peers with valid PE | — | 34.15x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Abiomed, Inc. (ABMD) measures how much investors pay for each dollar of the company's trailing earnings. ABMD's current PE ratio of N/A is calculated by dividing its stock price of $381.02 by its TTM earnings per share of —.
Frequently asked questions
ABMD pe ratio · 6 questionsABMD's current PE ratio is N/A as of 2026-06-09, based on a stock price of $381.02 and TTM EPS of —. Data sourced from Financial Modeling Prep via ABMD's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Abiomed, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09